ミトコンドリアフォスファタゼPGAM5をターゲットにすることで,NRF2媒介のFSP1発現を上調することでフェロプトーシスと急性炎を緩和します
Shuang Ma1, Jianhua Qin1, Jing Luan1
1The HIT Center for Life Sciences, School of Life Science and Technology, Harbin Institute of Technology, Harbin, China.
Cell death & disease
|February 21, 2026
まとめ
フォスフォグリセラートミュータゼ5 (PGAM5) は,細胞死経路であるフェロプトーシスを調節する. PGAM5を調節することで,保護タンパク質を上調することで細胞を保護し,急性炎のような疾患に対する潜在的な治療戦略を提供します.
科学分野:
- 細胞生物学 細胞生物学
- バイオケミストリー バイオケミストリー
- 病理学 パトロジー
背景:
- フェロプトーシスは,脂質過酸化を含む鉄に依存した死滅である.
- フォスフォグリセラートミュータゼ5 (PGAM5) は,ダイナミクスとストレスを調節するミトコンドリアのハブです.
- フェロプトーシスにおけるPGAM5の役割は,以前は不明でした.
研究 の 目的:
- フェロプトーシスにおけるPGAM5の機能を明らかにする.
- PGAM5がフェロプトーシスに影響を与える分子機構を調査する.
- 急性炎におけるPGAM5を標的とした治療の可能性を調査する.
主な方法:
- PGAM5.5の遺伝子削除と過剰発現
- 核因子エリソイド2関連因子2 (NRF2) とフェロプトーシス抑制タンパク質1 (FSP1) の発現の分析.
- 細胞エネルギーストレスの測定とAMP活性化タンパク質キナーゼ (AMPK) の活性化.
- 急性炎モデルにおけるPGAM5の薬理学的抑制.
主要な成果:
- PGAM5失調は,NRF2媒介のFSP1発現を上調することでフェロプトーシスから保護します.
- PGAM5の調節により,AMP/ATP比が増加し,AMPKが活性化されます.
- AMPKの活性化はNRF2の核蓄積とFSP1の転写を促進する.
- 薬理学的なPGAM5阻害は,アルギニン誘発の急性炎の重症を軽減しました.
結論:
- PGAM5はフェロプトーシスの重要な調節体である.
- PGAM5は,AMPKの活性化によるNRF2/FSP1経路を通じて細胞生存に影響を与えます.
- PGAM5を標的とした治療は,急性炎の治療に有望であることが示されています.
関連する概念動画
Cell Specific Gene Expression
13.4K
Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
13.4K
GPCRs Regulate Adenylyl Cylase Activity
6.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
6.9K
Gastritis-II: Pathophysiology
1.9K
Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.9K
Gastritis III: Clinical Manifestations and Management
1.9K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.9K
Gastritis II: Pathophysiology
89
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
89
Chronic Pancreatitis I: Introduction
29
Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80%...
29

